Stock Taper
SSKN
STRATA SKIN SCIENCES, INC.
OTC
$0.01
▲ UP 0.00% (0.00)

KEY STATISTICS

Market Cap$23.25 K
52w High$3.86
52w Low$0.00
Dividend Yield
Frequency
P/E
Volume4.88K
Shares Out.4.65M

COMPANY

LEADERSHIP

Erica Jordan
CHIEF EXECUTIVE
Erica Jordan

COMPENSATION 2026

Salary$508,882
Stock Awards$0
Incentive Plan Pay$63,699
All Other Comp.$28,800
Total$601,381

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 27, 2005
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
114

UPCOMING EARNINGS

DateNov 17, 2026
DayTuesday
Rev. Est.$5.41M
NOV
17
TUE

SPLIT RECORD

DATETYPERATIO
2024-06-07Reverse1:10
2017-04-07Reverse1:5
2014-07-10Reverse1:10

PRICE

$0.01 ▲ UP 0.00% (+$0.00)
OVERLAYS
$0.00$0.00$0.01$0.01$0.01$0.01$0.01$0.01$0.01$0.019:58 AM10:23 AM10:49 AM11:14 AM11:39 AM12:05 PM12:30 PM0.01

About STRATA Skin Sciences, Inc.

https://www.strataskinsciences.com ↗

STRATA Skin Sciences, Inc. develops and markets dermatologic treatment devices like XTRAC lasers globally for conditions such as psoriasis and acne, operating through dermatology procedures and equipment segments.

INDUSTRY

Medical - Devices

A PRODUCT STRATA SKIN SCIENCES, INC. IS KNOWN FOR

XTRAC Momentum 1.0
XTRAC Momentum 1.0

The XTRAC Momentum 1.0 is an advanced, high-power excimer laser for treating inflammatory skin conditions, featuring faster operation, a sleek design, and proven clinical adoption, enhancing the treatment experience.

COMPETITORS

COMPETITOR

Revenue by Products

IconPRODUCTQ2-2024Q3-2024Q4-2024Q1-2025
Dermatology Recurring Procedures$5.34M $5.38M $5.75M $4.73M
Dermatology Procedures Equipment$3.1M $3.42M $3.82M $2.08M

Revenue by Geography

MapREGIONQ1-2025Q2-2025Q3-2025Q4-2025
UNITED STATES$5.06M $5.22M $10.31M
Domestic$4.4M
CHINA$834K $1.66M $130K $1.57M
Middle East$711K $307K $172K $706K

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
39.55%
HOLDERS
1
TOP 1 OF 1 · RANKED BY POSITION SIZE
Broadfin Capital, LLC
1.8M sh · $3.83M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score1

INSIDER TRADES

DIRECTOR
Rubinstein Samuel
Sale · 5.5K shares
2025-11-17
DIRECTOR
Rubinstein Samuel
Purchase · 2.8K shares
2025-11-18
DIRECTOR
Rubinstein Samuel
Purchase · 2.2K shares
2025-11-18
DIRECTOR
Rubinstein Samuel
Sale · 7.2K shares
2025-11-17

SECTORS PEERS

PEERPRICE
PAVM$4.92COMPARE
NRSN$0.42COMPARE
BCLI$1.12COMPARE
BMRA$2.14COMPARE
HSCS$3.03COMPARE
ADIL$5.60COMPARE
ADXN$3.84COMPARE